期刊文献+

L-OHP联合5-Fu和CF治疗晚期大肠癌的疗效观察 被引量:1

The Clinical Observation of Oxaliplatin with 5-fluorouracil,Leucovorin in the Treatment of Advanced Colorectal Cancer
下载PDF
导出
摘要 目的 观察奥沙利铂联合 5 氟脲嘧啶、甲酰四氢叶酸钙治疗晚期大肠癌的近期疗效。方法 对 43例晚期大肠癌采用奥沙利铂 13 0mg/m2 静脉点滴 2h ,第 1天 ;甲酰四氢叶酸钙 2 0 0mg/m2 静脉点滴 2h ,第 1~ 5天 ;5 氟脲嘧啶 40 0mg/m2 静脉点滴 8h以上 ,第 1~ 5天。结果 全组CR 1例 ,PR 2 0例 ,总有效率为 48.8% (2 1/4 3 ) ,中位无进展生存期为 10 .1个月 ,中位生存期为 2 0 .7个月 ;主要不良反应为骨髓抑制、神经毒性反应 ,Ⅲ度白细胞减少发生率为 11.6% (5 /4 3 ) ,其它不良反应较轻。结论 奥沙利铂联合 5 氟脲嘧啶、甲酰四氢叶酸钙对晚期大肠癌有明显疗效 ,多数患者能耐受。 Objective To observe the clinical effect of Oxaliplatin with 5-fluorouracil,Leucovorin in the treatment of advanced colorectal cancer.Methods Forty-uhree patients with advanced colorectal cancer were selected and adopt Oxaliplation 130 mg/m2 intravenous drip 2 hours(the first day),Leucovorin 200 mg/m2 intravenous drip 2 hours(from the first day to the fifth day),5-fluorouracil 400 mg/m2 intravenous drip over 8 hours(from the first day to the fifth day).Results The total response rate of this group was 48.8%(21/43) including 1 CR and 20 PR.The median PFS was 10.1months and the median survival was 20.7 months.The main toxicities were Bone marrow depression and neurotoxicity,11.6%(5/43) patients developed Grade 3 WHO toxicity of leukopenia.other toxicities were mild.Conclusion Oxaliplatin with 5-fluorouracil,Leucovorin was obviously therapeutic effect in the treatment of advanced colorectal cancer.It could effectively extend the survival period.Most of patients could be tolerant.
出处 《实用癌症杂志》 2004年第5期523-524,529,共3页 The Practical Journal of Cancer
关键词 大肠癌 奥沙利铂 5-氟脲嘧啶 化学治疗 Colorectal Cancer Oxaliplatin(L-OHP) 5-fluorouracil(5-Fu) Chemotherapy
  • 相关文献

参考文献5

  • 1Rixe O, Ortuzar W, Alvarez M, et al. Oxaliplatin, tetraplatin,cisplatin,and carboplatin:spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel[J].Biochem Pharmacol,1996,52(6):1855.
  • 2Diaz-Rubio E,Satre J,Zaniboni A.Oxaliplatin as a single agent in previousely untreated colorectal carcinoma patient:a phase Ⅱ multicentric study[J].Ann Oncol,1998,9(1):105.
  • 3Zori Comba A,Blajman C,Richardet E,et al.A randomised phase Ⅱ study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid(Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients[J].Eur J Cancer,2001,37(8):1006.
  • 4Fischel JL,Formento P,Ciccolini J,et al.Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity[J].Br J Cancer,2002,86(7):1162.
  • 5孙燕,管忠震,金懋林,李维廉,李丽庆,石廷章,周立中,隋广杰,许立功,宋恕平,许德凤,李容,李扬,黄富麟,张嘉庆,张和平,鞠利雅.奥沙利铂单药或与氟尿嘧啶-甲酰四氢叶酸联合应用治疗晚期大肠癌Ⅱ期临床试用报告[J].癌症,1999,18(3):237-240. 被引量:344

二级参考文献2

共引文献343

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部